Gut microbiome: A potential indicator for predicting treatment outcomes in major depressive disorder
The therapeutic outcomes in major depressive disorder (MDD), one of the most common and heterogeneous mental illnesses, are affected by factors that remain unclear and often yield unsatisfactory results. Herein, we characterized the composition and metabolic function of the gut microbiota of patient...
Main Authors: | Zaiquan Dong, Xiaoling Shen, Yanni Hao, Jin Li, Haizhen Xu, Li Yin, Weihong Kuang |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-07-01
|
Series: | Frontiers in Neuroscience |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fnins.2022.813075/full |
Similar Items
-
Neferine alleviates chronic stress-induced depression by regulating monoamine neurotransmitter secretion and gut microbiota structure
by: Zaiquan Dong, et al.
Published: (2022-09-01) -
Changes of gut microbiome composition and metabolites associated with hypertensive heart failure rats
by: Lin Li, et al.
Published: (2021-05-01) -
16S rRNA gene sequencing reveals the effect of fluoxetine on gut microbiota in chronic unpredictable stress-induced depressive-like rats
by: Hui Dong, et al.
Published: (2023-08-01) -
Hybridization altered the gut microbiota of pigs
by: Limin Wei, et al.
Published: (2023-07-01) -
Gut Microbiome Composition Associated With Major Depressive Disorder and Sleep Quality
by: Qi Zhang, et al.
Published: (2021-05-01)